studyId: syn21355225 studyName: Evaluation of the use of antisense oligonucleotides as a personalized therapy for Neurofibromatosis Type 2 patients initiative: Drug Discovery Initiative Registered Reports fundingAgency: CTF
Drop files to upload
NF OSI Data Sharing Plan Template.pdf page is loading…